KIN Health review

What it is

KIN Health is the trading name of KIN Medical, Inc., a Delaware corporation whose registered address is a corporate-services office in Newark, Delaware. It describes itself as a technology platform rather than a medical practice or pharmacy. The clinicians who review intakes and prescribe are independent practitioners contracted through MD Integrations, a telehealth medical network, and KIN's terms say it pays MD Integrations a $20 fee for each medical review, which you aren't billed for. Medication is prepared by independent compounding pharmacies its terms name as Strive Pharmacy, Boothwyn Pharmacy in Kennett Square, Pennsylvania, and Drug Crafters Pharmacy in Frisco, Texas. Beyond weight loss, it sells compounded sermorelin, NAD⁺ and PT-141, each in injection, nasal-spray and dissolvable-tablet forms. It's self-pay only and doesn't accept insurance, Medicare or Medicaid. Contact is by email, with replies promised within one business day; medical questions go to your provider in the patient portal.

How it works

You start with an online quiz the site says takes about two minutes, then a fuller intake. A licensed provider reviews it, decides whether treatment is appropriate and sets your starting dose; the FAQ says most patients are prescribed within 24 hours, and KIN advertises an average provider response time of under an hour. Labs aren't required to start, though your provider may ask for them, and there's no in-person or video visit unless your situation calls for one. If you're prescribed, the pharmacy compounds the medication and ships it in plain packaging, usually within three to five business days. From there, care runs through portal messaging. Each month, before the next refill ships, you complete a check-in so your provider can review your progress and adjust the dose; skip it and nothing ships or charges. An anti-nausea medication, ondansetron, can be added during intake for $29 a month.

Pricing transparency

The GLP-1 page lists $99 for the first month for new patients on the starting dose, then $169 a month for compounded semaglutide or $199 a month for compounded tirzepatide. That price covers the medication with syringes and needles, the provider review, ongoing messaging, lab review if needed, and shipping, and there's no membership or consult fee on top. The page says the price stays the same at every dose. The terms add one exception: tirzepatide doses can use different vial strengths and pricing tiers, so your monthly cost may change as your provider raises the dose, with notice before the change. You're charged at checkout and refunded in full if a provider doesn't prescribe. Each refill is charged at the start of its cycle. You can cancel from the patient portal or by email, and a cancellation takes effect at the end of the current billing cycle. Once a refill has gone to the pharmacy for preparation, it can't be canceled or refunded, and shipped medication is final. KIN offers no satisfaction guarantee.

Branded vs compounded

KIN prescribes compounded semaglutide and compounded tirzepatide as weekly injections. Its terms state plainly that every compounded medication it offers is not FDA-approved and hasn't been evaluated by the FDA for safety, effectiveness or quality, and that formulations may include added ingredients such as glycine or vitamin B12 depending on the pharmacy. The weight-loss figures on its pages come from trials of the brand-name drugs, which it notes. Brand-name Wegovy, Ozempic, Zepbound and Mounjaro aren't offered. KIN says it is LegitScript-certified and shows a LegitScript badge, but the badge carries no certification number, so check its status on LegitScript's own site. Sermorelin, from $159, and NAD⁺, from $169 per 30-day supply, are sold separately. A search of the FDA warning-letter database under the company's name, trading name and web address returned no letters.

Pros and watch-outs

The evidence behind what KIN Health prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• Compounded vs branded GLP-1: regulatory status, sourcing and the evidence

  Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.

• Sermorelin benefits: does it work? What the trials show

  A real GHRH drug, read against the anti-aging pitch: an approved growth-hormone-releasing analog with a pediatric track record, and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

How KIN Health compares

A few alternatives worth a look, depending on what you’re optimizing for.

• Strut Health

  A general telehealth that covers GLP-1 alongside other everyday care

  See Strut Health →
• CoreAge Rx

  Flat pricing that does not climb as your dose titrates up

  See CoreAge Rx →
• Belle

  People who want a flat price that doesn't rise with the dose and regular dietitian check-ins

  See Belle →

More GLP-1 telehealth reviews: Goldspan Health · Lean Meds · Longevixx · Magnolia Regenerative Medicine · Mondae · NEUVÉ Health